» Articles » PMID: 11583947

Detection and Typing of Human Papillomavirus DNA in Penile Carcinoma: Evidence for Multiple Independent Pathways of Penile Carcinogenesis

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2001 Oct 5
PMID 11583947
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

To clarify the role of human papillomavirus (HPV) in penile cancer we evaluated the prevalence of HPV DNA in different histological subtypes of penile carcinoma, dysplasia, and condyloma using a novel, sensitive SPF10 HPV polymerase chain reaction assay and a novel genotyping line probe assay, allowing simultaneous identification of 25 different HPV types. Formalin-fixed, paraffin-embedded tissue samples were collected from the United States and Paraguay. HPV DNA was detected in 42% cases of penile carcinoma, 90% cases of dysplasia, and 100% cases of condyloma. There were significant differences in HPV prevalence in different histological cancer subtypes. Although keratinizing squamous cell carcinoma and verrucous carcinoma were positive for HPV DNA in only 34.9 and 33.3% of cases, respectively, HPV DNA was detected in 80% of basaloid and 100% of warty tumor subtypes. There was no significant difference in HPV prevalence between cases from Paraguay and the United States. In conclusion, the overall prevalence of HPV DNA in penile carcinoma (42%) is lower than that in cervical carcinoma (approximately 100%) and similar to vulvar carcinoma (approximately 50%). In addition, specific histological subtypes of penile cancer--basaloid and warty--are consistently associated with HPV, however, only a subset of keratinizing and verrucous penile carcinomas is positive for HPV DNA, and thus these two tumor groups seem to develop along different pathogenetic pathways.

Citing Articles

Evaluating HPV Vaccination-Related Content on a Burgeoning Social Media Platform: Insufficient Quality of TikTok.

Lin M, Ayo-Ajibola O, Castellanos C, West J, Luu N, Kokot N OTO Open. 2024; 8(4):e70052.

PMID: 39678371 PMC: 11646545. DOI: 10.1002/oto2.70052.


Human papillomavirus infection affects the immune microenvironment and antigen presentation in penile cancer.

Guimaraes S, Vale A, Rocha M, Butarelli A, da Silva J, de Deus A Front Oncol. 2024; 14:1463445.

PMID: 39493451 PMC: 11527599. DOI: 10.3389/fonc.2024.1463445.


Viral vector-based therapeutic HPV vaccines.

Ji T, Liu Y, Li Y, Li C, Han Y Clin Exp Med. 2024; 24(1):199.

PMID: 39196444 PMC: 11358221. DOI: 10.1007/s10238-024-01470-5.


Impact of HPV Vaccination on the Incidence of High-Grade Cervical Intraepithelial Neoplasia (CIN2+) in Women Aged 20-25 in the Northern Part of Norway: A 15-Year Study.

Mikalsen M, Simonsen G, Sorbye S Vaccines (Basel). 2024; 12(4).

PMID: 38675803 PMC: 11054067. DOI: 10.3390/vaccines12040421.


Human Papilloma Virus-Infected Cells.

Cruz-Gregorio A, Aranda-Rivera A Subcell Biochem. 2023; 106:213-226.

PMID: 38159229 DOI: 10.1007/978-3-031-40086-5_8.


References
1.
Frisch M, Goodman M . Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S. Cancer. 2000; 88(6):1464-9. DOI: 10.1002/(sici)1097-0142(20000315)88:6<1464::aid-cncr26>3.0.co;2-o. View

2.
Bosch F, Manos M, Munoz N, Sherman M, Jansen A, Peto J . Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995; 87(11):796-802. DOI: 10.1093/jnci/87.11.796. View

3.
Cubilla A, Velazques E, Reuter V, Oliva E, Mihm Jr M, Young R . Warty (condylomatous) squamous cell carcinoma of the penis: a report of 11 cases and proposed classification of 'verruciform' penile tumors. Am J Surg Pathol. 2000; 24(4):505-12. DOI: 10.1097/00000478-200004000-00004. View

4.
Wabinga H, Parkin D, Wabwire-Mangen F, Nambooze S . Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer. 2000; 82(9):1585-92. PMC: 2363394. DOI: 10.1054/bjoc.1999.1071. View

5.
Gillison M, Koch W, Capone R, Spafford M, Westra W, Wu L . Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92(9):709-20. DOI: 10.1093/jnci/92.9.709. View